Viewing Study NCT05848258


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2025-12-30 @ 2:53 AM
Study NCT ID: NCT05848258
Status: RECRUITING
Last Update Posted: 2025-12-09
First Post: 2023-04-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module